Sulfalen
CAS No. 152-47-6
Sulfalen( AS-18908 | AS18908 | AS 18908 | Sulfametopyrazine | Sulfalen | Sulfalene )
Catalog No. M12130 CAS No. 152-47-6
Sulfalene is a long-acting sulfonamide antibiotic used for the treatment of chronic bronchitis, urinary tract infections and malaria.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | 32 | In Stock |
|
| 500MG | 51 | In Stock |
|
| 1G | 74 | In Stock |
|
Biological Information
-
Product NameSulfalen
-
NoteResearch use only, not for human use.
-
Brief DescriptionSulfalene is a long-acting sulfonamide antibiotic used for the treatment of chronic bronchitis, urinary tract infections and malaria.
-
DescriptionSulfalene is a long-acting sulfonamide antibiotic used for the treatment of chronic bronchitis, urinary tract infections and malaria.
-
In Vitro——
-
In Vivo——
-
SynonymsAS-18908 | AS18908 | AS 18908 | Sulfametopyrazine | Sulfalen | Sulfalene
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorDHPS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number152-47-6
-
Formula Weight280.3
-
Molecular FormulaC11H12N4O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=S(C1=CC=C(N)C=C1)(NC2=NC=CN=C2OC)=O
-
Chemical Name4-amino-N-(3-methoxypyrazin-2-yl)benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Nilotinib hydrochlor...
Nilotinib hydrochloride(AMN-107 HCl) is an orally available Bcr-Abl tyrosine kinase inhibitor with antitumor activity for modulation of neuroinflammation and cognitive deficits, and may be used in studies of chronic myelogenous leukemia.
-
DC661
DC661 (DC-661) is a novel dimeric chloroquine (CQ) that is capable of deacidifying the lysosome and inhibiting autophagy significantly better than HCQ, targets palmitoyl-protein thioesterase 1 (PPT1).
-
2,2-Dihydroxy chalco...
2,2'-Dihydroxy chalcone is a potent inhibitor of β-glucuronidase (IC50=1.6±0.2 μM) and lysozyme (IC50=1.4±0.2 μM) release from rat neutrophils stimulated with fMLP/CB.2,2'-Dihydroxy chalcone has inhibitory activity against Escherichia coli, Shigella fowleri, Staphylococcus albicans and Staphylococcus aureus.
Cart
sales@molnova.com